This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Sexual Dysfunction on Fluvoxamine Therapy

Lyle K. Laird

Published: June 30, 2000

Article Abstract

Letter to the Editor

Sir: I noted with great interest the study by Nafziger et al. (March 1999 issue) entitled "Incidence of Sexual Dysfunction in Healthy Volunteers on Fluvoxamine Therapy." This study’s premise is timely and its results could potentially be of significant clinical impact given the sheer number of newer anxiolytics and antidepressants currently being used in practice. It was an interesting article, but I identified a few problems I had with this study.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Depression (MDD) , Sexual Dysfunction

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...